Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

PARP inhibition in cancer therapy

22 ta ish

  1. Lytic and sublytic effects of gossypol on red blood cells and thymocytes

    Nargiza M. Chorieva, Diyor D. Fayziev, Nargiza A. Tsiferova +7

    MaqolaPARP inhibition in cancer therapyClinical and Experimental Pharmacology and Physiology20209 iqtibos
    ABI

  2. The Potential Contribution of BRCA Mutations to Early Onset and Familial Breast Cancer in Uzbekistan

    Abdulla Abdikhakimov, Mukaddas Tukhtaboeva, Bakhtiyar Adilov +1

    MaqolaOchiq kirishBRCA gene mutations in cancerCentral Asian Journal of Global Health20162 iqtibos
    ABI

  3. Mathematical modeling of regulatory mechanisms of cardiological pathologies in the tumor process

    Mahruy Saidalieva, Margarita Gildieva, Anvar Abduvaliev +1

    MaqolaChemotherapy-induced cardiotoxicity and mitigation2019 International Conference on Information Science and Communications Technologies (ICISCT)20192 iqtibos
    ABI

  4. Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone

    Muzaffar Kayumov, Jia Li, Azizbek Pardaev +9

    MaqolaPARP inhibition in cancer therapyEuropean Journal of Medicinal Chemistry20222 iqtibos
    ABI

  5. Down-regulation of poly (ADP-ribose) polymerase 1 leads to change of hydroquinone cytotoxicity in TK6 cells.

    Yan Sha, Wei Zhou, Zhenyu Yang +4

    MaqolaPARP inhibition in cancer therapyPubMed20150 iqtibos
    ABI

  6. BEVACIZUMAB AS MAINTENANCE TREATMENT IN PATIENTS WITH OVARIAN CANCER

    O. Akhmedov

    MaqolaOchiq kirishOvarian cancer diagnosis and treatmentEurasianUnionofScientists20190 iqtibos
    ABI

  7. The role of p53 gene suppressor and Bcl-2 oncoprotein in germ cell ovarian tumor prognosis determination among child and adolescent patients

    Anvar T. Shukullaev

    MaqolaOchiq kirishTesticular diseases and treatmentsPediatric Hematology Oncology Journal20200 iqtibos
    ABI

  8. Frequencies of the C1236T, G2677T/A, and C3435T Polymorphisms of the MDR1 Gene and their Haplotypes in Uzbekistan

    S. B. Nurmatova, Abrorjon Abdurakhimov, O. S. Charishnikova +2

    MaqolaOchiq kirishDrug Transport and Resistance MechanismsAmerican journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology20220 iqtibos
    ABI

  9. TARGETED THERAPY IN THE PALLIATIVE TREATMENT OF PLATINUM-RESISTANT RECURRENT OVARIAN CANCER COMPLICATED BY ASCITES

    Sh.Sh. Shakhanova, J.A. Abdurakhmonov, N.M. Rakhimov

    MaqolaOchiq kirishOvarian cancer diagnosis and treatmentThe American Journal of Medical Sciences and Pharmaceutical Research20230 iqtibos
    ABI

  10. Cardiac Injury Following Chemo/Radiation Therapy: An Updated Reviewon Mechanisms and Therapeutic Approaches

    Krishanveer Singh, Ameer A. Alameri, Ammar Ali Hamza +7

    Sharh maqolaChemotherapy-induced cardiotoxicity and mitigationCurrent Radiopharmaceuticals20230 iqtibos
    ABI

  11. Current Developments and Innovations in Early Detection and Subsequent Treatment of Cancer

    Altin Goxharaj, Nizom Suyunov, E.L. Nikolaev +2

    MaqolaOchiq kirishCancer Genomics and DiagnosticsJournal of cancer research updates20240 iqtibos
    ABI

  12. The efficacy of PARP inhibitors in the treatment of patients with synchronous breast cancer.

    Kamila Izrailbekova, Sergey Kamishov, Sunnatilla Saydullaev +4

    MaqolaOchiq kirishPARP inhibition in cancer therapyJournal of Clinical Oncology20240 iqtibos
    ABI

  13. Structure-driven design and precision translation of functionally diverse isatin-based CDK2 inhibitors: Advances in SAR, polypharmacology, and biomarker-guided cancer therapy

    Safia Obaidur Rab, A. Al-Shahrani, Lalji Baldaniya +9

    MaqolaCancer-related Molecular PathwaysJournal of Molecular Structure20250 iqtibos
    ABI

  14. A comprehensive review of immunotherapy in gastrointestinal tumors with a focus on the role of combination therapy with PARP inhibitors

    Saade Abdalkareem Jasim, Jitendra Gupta, Subasini Uthirapathy +7

    Sharh maqolaCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 iqtibos
    ABI

  15. Diagnostic Performance of ROMA and Biomarkers in Ovarian Cancer: A Systematic Review of Sensitivity, Specificity, and Menopausal Influence

    Dilfuza Botirjonovna Mirzaeva, Dilshod Tolibov, Kalash Dwivedi

    MaqolaOchiq kirishOvarian cancer diagnosis and treatmentIndian Journal of Medical and Paediatric Oncology20260 iqtibos
    ABI

  16. Abstract 2510: Comprehensive genomic profiling drives precision oncology and expands accessibility to targeted therapies in Uzbek populations

    Zilola Avazovna Olimova, Gowhar Shafi, D. Farrukh +10

    MaqolaCancer Genomics and DiagnosticsCancer Research20260 iqtibos
    ABI

  17. OVARIAN CANCER: MORPHOLOGY, CLINICAL FEATURES AND MODERN APPROACHES TO SCREENING AND PREVENTION

    Abror Abduxoliq ugli Rajabbayev

    MaqolaOvarian cancer diagnosis and treatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  18. OVARIAN CANCER: MORPHOLOGY, CLINICAL FEATURES AND MODERN APPROACHES TO SCREENING AND PREVENTION

    Abror Abduxoliq ugli Rajabbayev

    MaqolaOchiq kirishOvarian cancer diagnosis and treatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  19. OVARIAN CANCER: MORPHOLOGY, CLINICAL FEATURES AND MODERN APPROACHES TO SCREENING AND PREVENTION

    Abror Abduxoliq ugli Rajabbayev

    MaqolaOvarian cancer diagnosis and treatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  20. OVARIAN CANCER: MORPHOLOGY, CLINICAL FEATURES AND MODERN APPROACHES TO SCREENING AND PREVENTION

    Abror Abduxoliq ugli Rajabbayev

    MaqolaOchiq kirishOvarian cancer diagnosis and treatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  21. Resveratrol-loaded liposomes regulate mitochondrial oxidative stress through the HIGD1A/NF-κB/SOD2 signaling pathway to improve chemotherapy-induced ovarian injury

    Shuhong Yang, Chendi Zhang, Diyorakhon Nabieva +2

    MaqolaOchiq kirishSirtuins and Resveratrol in MedicineNanomedicine20260 iqtibos
    ABI

  22. Liposomes containing histidine overcome poly ADP-ribose polymerase inhibitor resistance

    Jing Zhang (23775), Muhammad Tufail, Yun Deng +11

    MaqolaOchiq kirishPARP inhibition in cancer therapyDrug Resistance Updates20260 iqtibos
    ABI